Inventor · disambiguated record
John Bell
Also filed as: BELL JOHN · BELL JOHN C · BELL JOHN CAMERON · BELL JOHN IRVING
29 granted patents·31 pending applications·141 citations·filing 2000–2023
95Inventor score
Files withTURNSTONE LP14OTTAWA HOSPITAL RES INST11BELL JOHN C4CELVERUM INC3OTTAWA HEALTH RESEARCH INST3
Top patents by PatentIndex Score
60 records- 0195US7731974B2Mutant vesicular stomatitis viruses and uses thereofOTTAWA HOSPITAL RES INST·Filed 2004·Granted Jun 8, 2010·66 cites·17 claims
- 0286US7192580B2Purging of cells using virusesUNIV OTTAWA·Filed 2003·Granted Mar 20, 2007·24 cites·10 claims
- 0384US9045729B2Oncolytic rhabdovirusBELL JOHN C·Filed 2010·Granted Jun 2, 2015·8 cites·32 claims
- 0481US10603351B2Engineered synergistic oncolytic viral symbiosisBELL JOHN C·Filed 2009·Granted Mar 31, 2020·2 cites·6 claims
- 0580US8940291B2Compositions and methods for enhancing virus efficacyBELL JOHN·Filed 2010·Granted Jan 27, 2015·6 cites·6 claims
- 0679US9919047B2Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusKIRN DAVID·Filed 2012·Granted Mar 20, 2018·5 cites·24 claims
- 0779US7582614B2Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infectionROBARTS RES INST·Filed 2004·Granted Sep 1, 2009·12 cites·20 claims
- 0878US8481023B2Oncolytic rhabdovirusSTOJDL DAVID·Filed 2007·Granted Jul 9, 2013·4 cites·4 claims
- 0978US8227440B2Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infectionMCFADDEN GRANT·Filed 2009·Granted Jul 24, 2012·3 cites·15 claims
- 1074US9719105B2Methods and compositions for production of vaccinia virusKIRN DAVID·Filed 2012·Granted Aug 1, 2017·2 cites·27 claims
- 1173US2021187048A1Oncolytic rhabdovirusTURNSTONE LP·Filed 2020·Application pending·0 cites
- 1272US10660947B2Vaccine compositionTURNSTONE LP·Filed 2019·Granted May 26, 2020·0 cites·27 claims
- 1372US10434169B2Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virusSILLAJEN BIOTHERAPEUTICS INC·Filed 2018·Granted Oct 8, 2019·1 cites·13 claims
- 1472US10363293B2Vaccine compositionTURNSTONE LP·Filed 2014·Granted Jul 30, 2019·2 cites·21 claims
- 1571US10646557B2Vaccine compositionTURNSTONE LP·Filed 2019·Granted May 12, 2020·0 cites·13 claims
- 1670US8282917B2Mutant viruses and uses thereofBELL JOHN C·Filed 2010·Granted Oct 9, 2012·1 cites·25 claims
- 1770US2023285552A1Oncolytic viruses as adjuvantsTURNSTONE LP·Filed 2023·Application pending·0 cites
- 1869US10767166B2Methods and compositions for production of vaccina virusSILLAJEN BIOTHERAPEUTICS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 1969US8147822B1Oncolytic virusBELL JOHN C·Filed 2000·Granted Apr 3, 2012·2 cites·41 claims
- 2067US9572883B2Oncolytic rhabdovirusTURNSTONE LTD PARTNERSHIP·Filed 2013·Granted Feb 21, 2017·1 cites·5 claims
- 2166US11110138B2Non-replicating virus-derived particles and uses thereofCELVERUM INC·Filed 2013·Granted Sep 7, 2021·1 cites·7 claims
- 2266US9623096B2Virally infected hematopoietic cells and uses thereofCELVERUM INC·Filed 2012·Granted Apr 18, 2017·1 cites·17 claims
- 2364US2024026380A1Microrna-based compositions and methods used in disease treatmentOTTAWA HOSPITAL RES INST·Filed 2023·Application pending·0 cites
- 2464US2021128706A1Vaccine compositionTURNSTONE LP·Filed 2020·Application pending·0 cites
- 2563US2024229069A9Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2023·Application pending·0 cites
- 2663US2018369303A1Oncolytic rhabdovirusTURNSTONE LP·Filed 2018·Application pending·0 cites
- 2760US10604741B2Compositions and methods for enhancing virus replicationTURNSTONE LP·Filed 2018·Granted Mar 31, 2020·0 cites·14 claims
- 2860US2020397892A1Oncolytic viruses as adjuvantsTURNSTONE LP·Filed 2019·Application pending·0 cites
- 2959US2017165305A1Oncolytic rhabdovirusTURNSTONE LTD PATNERSHIP·Filed 2017·Application pending·0 cites
- 3058US2011044952A1Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitorsOTTAWA HEALTH RESEARCH INST·Filed 2008·Application pending·0 cites
- 3157US9283254B2Compositions and methods for enhancing virus efficacyOTTAWA HOSPITAL RES INST·Filed 2014·Granted Mar 15, 2016·0 cites·9 claims
- 3257US2007166287A1Oncolytic virusWELLSTAT BIOLOGICS CORP·Filed 2007·Application pending·0 cites
- 3356US10066214B2Compositions and methods for enhancing virus replicationOTTAWA HOSPITAL RES INST·Filed 2014·Granted Sep 4, 2018·0 cites·12 claims
- 3456US2021346441A1Non-replicating virus-derived particles and uses thereofCELVERUM INC·Filed 2021·Application pending·0 cites
- 3556US2007141033A1Purging of cells using virusesUNIV OTTAWA·Filed 2007·Application pending·0 cites
- 3655US11739350B2MicroRNA-based compositions and methods used in disease treatmentOTTAWA HOSPITAL RES INST·Filed 2019·Granted Aug 29, 2023·0 cites·2 claims
- 3755US2004170607A1Oncolytic virusFiled 2003·Application pending·0 cites
- 3855US2023022757A1Modified vaccinia vectorsOTTAWA HOSPITAL RES INST·Filed 2022·Application pending·0 cites
- 3955US2004208849A1Oncolytic virusFiled 2003·Application pending·0 cites
- 4055US2019070280A1Oncolytic virus and checkpoint inhibitor combination therapyTURNSTONE LP·Filed 2018·Application pending·0 cites
- 4154US10202581B2Methods and compositions for production of vaccinia virusSILLAJEN BIOTHERAPEUTICS INC·Filed 2017·Granted Feb 12, 2019·0 cites·19 claims
- 4254US2024245804A1Expression of Bacterial Dinucleotide CyclasesUNIV MCMASTER·Filed 2022·Application pending·0 cites
- 4353US11802292B2Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Granted Oct 31, 2023·0 cites·50 claims
- 4450US2019022203A1Oncolytic virus and checkpoint inhibitor combination therapyTURNSTONE LP·Filed 2017·Application pending·0 cites
- 4550US2018064805A1Method of Vaccination Comprising a Histone Deacetylase InhibitorTURNSTONE LP·Filed 2017·Application pending·0 cites
- 4649US9896664B2Oncolytic rhabdovirusOTTAWA HOSPITAL RES INST·Filed 2015·Granted Feb 20, 2018·0 cites·21 claims
- 4749US2023203532A1Recombinant polypeptides for programming extracellular vesiclesUNIV MCMASTER·Filed 2020·Application pending·0 cites
- 4849US2022380799A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
- 4947US2010086522A1Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic virusesOTTAWA HEALTH RESEARCH INST·Filed 2007·Application pending·0 cites
- 5047US2022056480A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →